AI in Medical Devices: Navigating the Compliance Maze

AI-enabled medical devices sit at the intersection of two demanding regimes. Here's how to manage overlapping obligations without duplicating effort.

AI is transforming medical devices — from diagnostic imaging to patient-monitoring and decision-support tools. But this innovation lands squarely at the intersection of two of the most demanding regulatory regimes in existence: medical-device regulation and AI regulation. Managing both at once is where many manufacturers struggle.

Two regimes, overlapping demands

Medical devices in the EU are governed by the Medical Device Regulation (MDR), which already imposes rigorous requirements around safety, clinical evidence, risk management, and post-market surveillance. The EU AI Act layers additional AI-specific obligations on top — and treats many AI-enabled devices as high-risk.

Where the regimes align

• Risk management — ISO 14971 practices map closely to AI risk requirements.
• Quality management — an ISO 13485 system provides a strong foundation.
• Technical documentation — much of what MDR requires overlaps with AI Act needs.
• Post-market surveillance — both regimes demand ongoing monitoring.

The smart approach is integration: build one coherent system that satisfies both regimes, rather than running parallel programs that duplicate work.

A pragmatic path forward

Manufacturers who already have mature MDR and quality systems are further along than they think. The key is to map existing controls against AI-specific requirements, identify the genuine gaps — typically around data governance, transparency, and human oversight — and extend the existing system to close them.

With deep roots in both medical devices and compliance, this is exactly the kind of overlapping challenge our team was built to solve — turning a daunting maze into a single, navigable route.